Severe acute respiratory syndrome (
The last infected human case was reported in 2004. However, SARS is not claimed to have been eradicated, as it may still be present in its natural host reservoirs (animal populations) and can return into the human population in the future.
SARS usually spreads through close person-to-person contact. The hallmark symptoms of SARS include cough, breathing difficulty, high fever and other respiratory symptoms.
Currently available diagnostic tests have some limitations. Many of the tests are unable to accurately diagnose SARS early, when treatment is most needed.
Treatment of SARS includes patient isolation and supportive therapy with the use antipyretics, supplemental oxygen and ventilation support as needed. SARS is still a puzzle to scientists and poses challenges to the best of brains in search of viable treatment options. Several pieces of the puzzle are slowly falling into place, as the world awaits a treatment strategy to combat this condition.
The death rate from SARS is 9-12% of the total reported cases. The prognosis of SARS is poor in the elderly with the death rate being 50% in people aged above 65-years. Younger patients showed better recovery. In some patients, SARS results in severe long-term sequelae like pulmonary fibrosis, osteoporosis and femoral necrosis. This leads to complete loss of ability to work or take care of self due to which some of the patients suffer from major depressive disorder.
Thanks to modern medicine we are no longer forced to endure prolonged pain, disease, discomfort and wealth. - Robert Orben
Latest Publications and Research on SARSPreliminary estimation of the basic reproduction number of novel coronavirus (2019-nCoV) in China, from 2019 to 2020: A data-driven analysis in the early phase of the outbreak. - Published by PubMed
SARS-CoV, MERS-CoV and now the 2019-novel CoV: Have we investigated enough about coronaviruses? - A bibliometric analysis. - Published by PubMed
Emergence of SARS-like Coronavirus poses new challenge in China. - Published by PubMed
Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. - Published by PubMed
Recent discovery and development of inhibitors targeting coronaviruses. - Published by PubMed